Overview

Sequenced Treatment in Adolescents With Major Depression (STAMD): a Multicenter Open-label Randomized Controlled Trial

Status:
Recruiting
Trial end date:
2027-07-01
Target enrollment:
Participant gender:
Summary
The aim of this project is to investigate the effectiveness of existing common antidepressants and to provide new evidence for depressed children and adolescents who are not responding to their first treatment.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
First Affiliated Hospital of Chongqing Medical University
Collaborator:
Second Xiangya Hospital of Central South University
Treatments:
Aripiprazole
Duloxetine Hydrochloride
Fluoxetine
Lithium Carbonate
Olanzapine
Sertraline
Vortioxetine